Blood test identified a DNA methylation marker linked to lifetime cannabis use
An epigenome-wide study of over 2,500 women identified and replicated a blood-based DNA methylation site associated with lifetime cannabis use, though its predictive accuracy was modest.
Quick Facts
What This Study Found
Researchers identified a replicated association between lifetime cannabis use and DNA methylation at site cg15973234 in the CEMIP gene (combined P = 3.3 x 10^-8). The methylation-based classifier had modest predictive accuracy with AUC of 0.60 in discovery and 0.54 in replication samples.
Key Numbers
Discovery N = 1,730 (855 ever-users); replication N = 853 (392 ever-users); cg15973234 in CEMIP gene P = 3.3 x 10^-8; AUC 0.60 discovery, 0.54 replication
How They Did This
Epigenome-wide association study using blood-based DNA methylation data from a case-cohort within the Sister Study (discovery N = 1,730; replication N = 853). Researchers tested associations between methylation at over 450,000 sites and self-reported lifetime cannabis use.
Why This Research Matters
Objective biomarkers of cannabis use are needed for epidemiological research. While urine and blood tests detect recent use, DNA methylation could potentially serve as a marker of cumulative lifetime exposure, capturing long-term use patterns that self-report may miss.
The Bigger Picture
This is the first blood-based epigenome-wide study of cannabis use. While the predictive accuracy is too modest for clinical use, the replicated finding at CEMIP suggests cannabis leaves a detectable molecular footprint that could improve epidemiological research.
What This Study Doesn't Tell Us
All-female cohort (Sister Study) limits generalizability. Modest predictive accuracy. Cannot distinguish frequency, recency, or duration of use. Self-reported cannabis use as the comparator.
Questions This Raises
- ?Does this methylation change have functional consequences?
- ?Would it perform better in populations with heavier use patterns?
- ?Could combining multiple methylation sites improve prediction?
- ?Does the CEMIP methylation change persist after cessation?
Trust & Context
- Key Stat:
- First replicated blood-based epigenetic marker of lifetime cannabis use
- Evidence Grade:
- Well-powered EWAS with independent replication, though the effect size is small and the cohort is all-female.
- Study Age:
- Published in 2021.
- Original Title:
- Epigenome-wide analysis uncovers a blood-based DNA methylation biomarker of lifetime cannabis use.
- Published In:
- American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 186(3), 173-182 (2021)
- Authors:
- Markunas, Christina A, Hancock, Dana B(5), Xu, Zongli(2), Quach, Bryan C, Fang, Fang, Sandler, Dale P, Johnson, Eric O, Taylor, Jack A
- Database ID:
- RTHC-03323
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Can a blood test tell if someone has ever used cannabis?
This study found a DNA methylation signal associated with lifetime cannabis use, but its accuracy was too modest (AUC 0.54-0.60) for reliable individual-level detection.
What is DNA methylation?
DNA methylation is a chemical modification to DNA that can change how genes are expressed without altering the genetic code itself. Environmental exposures, including substance use, can alter methylation patterns.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-03323APA
Markunas, Christina A; Hancock, Dana B; Xu, Zongli; Quach, Bryan C; Fang, Fang; Sandler, Dale P; Johnson, Eric O; Taylor, Jack A. (2021). Epigenome-wide analysis uncovers a blood-based DNA methylation biomarker of lifetime cannabis use.. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 186(3), 173-182. https://doi.org/10.1002/ajmg.b.32813
MLA
Markunas, Christina A, et al. "Epigenome-wide analysis uncovers a blood-based DNA methylation biomarker of lifetime cannabis use.." American journal of medical genetics. Part B, 2021. https://doi.org/10.1002/ajmg.b.32813
RethinkTHC
RethinkTHC Research Database. "Epigenome-wide analysis uncovers a blood-based DNA methylati..." RTHC-03323. Retrieved from https://rethinkthc.com/research/markunas-2021-epigenomewide-analysis-uncovers-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.